Novel benzimidazole derivatives as selective CB2 agonists

Bioorg Med Chem Lett. 2008 Jul 1;18(13):3695-700. doi: 10.1016/j.bmcl.2008.05.073. Epub 2008 May 22.

Abstract

The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.

MeSH terms

  • Benzimidazoles / chemical synthesis
  • Benzimidazoles / chemistry*
  • Binding, Competitive
  • Cannabinoid Receptor Modulators / chemistry
  • Cannabinoids / chemistry
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Humans
  • Models, Chemical
  • Receptor, Cannabinoid, CB1 / chemistry
  • Receptor, Cannabinoid, CB2 / chemistry*
  • Receptors, Cannabinoid / chemistry
  • Structure-Activity Relationship
  • Technology, Pharmaceutical / methods

Substances

  • Benzimidazoles
  • Cannabinoid Receptor Modulators
  • Cannabinoids
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • Receptors, Cannabinoid
  • benzimidazole